Bürkert Global


Search the Bürkert Website

Search by Type  
Search by Text  

DNA vaccines

DNA vaccines offer clear advantages over conventional vaccines (on the basis of inactivated viruses or bacteria). They are tolerated better, cost less to produce and are easier to store. This involves injecting DNA molecules bearing the hereditary information for specific antigens of the pathogen. Today, DNA vaccines are produced on a 10-100 gram scale.

Top of Page    PDF    Print